Login / Signup

Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease.

Kari Ann ShireyWendy LaiLindsey J BrownJorge C G BlancoRobert BeadenkopfYajing WangStefanie N VogelGreg A Snyder
Published in: Innate immunity (2020)
Keyphrases
  • high glucose
  • diabetic rats
  • cancer therapy
  • drug induced
  • drug delivery